CONEXEU SCIENCES (CNXU) Stock Price, News & Analysis
Why is CNXU Stock Down Today?
Company Description
CONEXEU SCIENCES (NASDAQ: CNXU) is classified in the biotechnology industry within the Orthopedic, Prosthetic & Surgical Appliances & Supplies sector and carries a market capitalization of $157.1M, ranking #4,766 among all listed U.S. companies by market cap.
This page collects what Stock Titan holds for CNXU, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
CONEXEU SCIENCES (CNXU) stock last closed at $5.87. At a market capitalization of $157.1M, CNXU is classified as a micro-cap stock with approximately 26.8M shares outstanding.
Latest News
CONEXEU SCIENCES has 10 recent news articles, with the latest published today. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. View all CNXU news →
SEC Filings
CONEXEU SCIENCES has filed 5 recent SEC filings, including 3 Form SCHEDULE 13G, 1 Form D, 1 Form SCHEDULE 13D. The most recent filing was submitted on August 31, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CNXU SEC filings →
Insider Radar
Insider buying activity at CONEXEU SCIENCES over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.
Financial Highlights
Upcoming Events
Nasdaq LD Micro Summit
H.C. Wainwright Conference
Biotech on Tap Event
510(k) FDA submission
510(k) submission
510(k) submission
CONEXEU SCIENCES has 6 upcoming scheduled events. The next event, "Nasdaq LD Micro Summit", is scheduled for September 9, 2026 (in 7 days). Investors can track these dates to stay informed about potential catalysts that may affect the CNXU stock price.
Short Interest History
Short interest in CONEXEU SCIENCES (CNXU) currently stands at 129.5 thousand shares, down 12.4% from the previous reporting period, representing 0.8% of the float. Since May 2026, short interest has increased by 498.3%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for CONEXEU SCIENCES (CNXU) currently stands at 1.0 days, down 20.6% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
CNXU Company Profile & Sector Positioning
CONEXEU SCIENCES (CNXU) operates in the Biotechnology industry within the broader Orthopedic, Prosthetic & Surgical Appliances & Supplies sector and is listed on the NASDAQ.
Conexeu Sciences (Nasdaq: CNXU), a preclinical-stage biotechnology company developing the CXU™ regenerative tissue platform, announced its participation in three investor and industry conferences in September and October 2026. Management will present and hold meetings at the Nasdaq / LD Micro Summit Series on September 9, 2026 in San Francisco; the H.C. Wainwright 28th Annual Global Investment Conference on September 14–16, 2026 in New York; and H.C. Wainwright’s 2026 Biotech on Tap event on October 1–3, 2026 in Munich. These events will feature CEO Miles Harrison and senior executives engaging with investors and industry stakeholders as Conexeu advances its predicate-based U.S. regulatory strategy toward an anticipated 510(k) submission in early 2027 for its Ten-Minute Tissue™ ECM device.